The SCLC component showed higher positive rates for synaptophysin, CD56, ASCL1, and INSM1, and a higher labeling index for Ki67 compared to the NSCLC component (Table 2 and Figure S1). This evidence concerns the gene INSM1 and non-small cell lung carcinoma.